Grade: D — Significant Concerns
Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles
Data: SEC EDGAR 10-K (Filed 2026-01-22) + Yahoo Finance
Auditor: Ernst & Young LLP — Clean opinion (2 Critical Audit Matters)
One-line verdict: Intel's FY2025 net loss of $267M looks like recovery after FY2024's $18.8B catastrophe — it is not. The 10-K reveals a company being pulled apart by gravity: Intel Foundry lost $10.3B on $17.8B revenue (of which only $307M came from external customers), the DCAI server business grew just 5% while competitors posted triple-digit AI revenue growth, and FCF has been negative for three consecutive years (-$14.3B, -$15.7B, -$4.9B). Accounts receivable outpaced revenue for two consecutive years. Goodwill of $23.9B includes $8.3B allocated to Mobileye, which already took a $2.8B impairment in 2024 and whose stock price suggests more may follow. Intel converted $7.9B in CHIPS Act funding into government equity, diluting shareholders by 15%. The M-Score of -2.59 reads "clean" — but this metric has limited value for a company that lost money in two of the last three years.
| Metric | Result |
|---|---|
| Red Flags | **2** |
| Watch Items | **4** |
| Checks Completed | **18/18** |
| Beneish M-Score | **-2.59** (clean, but limited diagnostic value for loss-making companies) |
| F-Score (Fraud Probability) | **0.67** (0.25% probability) |
| Altman Z-Score | **3.25** (safe zone — solvency intact for now) |
| Auditor | Ernst & Young LLP — Unqualified opinion |
| Fiscal Year | 2025 (ended December 27, 2025) |
| Report Date | 2026-04-05 |
Two Companies, One Dying
Intel is effectively two businesses: a profitable CPU company (Intel Products) and a money-burning foundry (Intel Foundry) that cannot attract external customers.
Per the 10-K segment disclosures:
| Segment | FY2025 Revenue | Operating Income (Loss) | Margin |
|---|---|---|---|
| CCG (Client Computing) | $32,228M | $9,317M | 29% |
| DCAI (Data Center & AI) | $16,919M | $3,422M | 20% |
| **Intel Products Total** | **$49,147M** | **$12,739M** | **26%** |
| **Intel Foundry** | **$17,826M** | **-$10,318M** | **-58%** |
| All Other (Mobileye, etc.) | $3,706M | $247M | 7% |
Intel Foundry's $17.8B revenue is almost entirely internal: the filing states external revenue was only "$307 million, up $148 million from 2024." Three years of Foundry operating losses:
| Year | Revenue | Operating Loss | Loss Margin |
|---|---|---|---|
| FY2023 | $18,504M | -$7,083M | -38% |
| FY2024 | $17,317M | -$13,291M | -77% |
| FY2025 | $17,826M | -$10,318M | -58% |
| **3-Year Total Loss** | -- | **-$30,692M** | -- |
The filing explains: "Operating loss was $10.3 billion in 2025, compared to an operating loss of $13.3 billion in 2024, primarily due to a reduction in asset impairments and accelerated depreciation charges. In 2025, we incurred $950 million of asset impairments and accelerated depreciation charges related to certain manufacturing assets."
Consolidated Results: The Illusion of Stability
Per the consolidated statements of operations:
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Revenue | $54,228M | $53,101M | $52,853M |
| Cost of Sales | $32,517M | $35,756M | $34,478M |
| Gross Profit | $21,711M | $17,345M | $18,375M |
| Gross Margin | 40.0% | 32.7% | 34.8% |
| R&D | $16,046M | $16,546M | $13,774M |
| Marketing/G&A | $5,634M | $5,507M | $4,624M |
| Restructuring | -$62M | $6,970M | $2,191M |
| Operating Income (Loss) | $93M | -$11,678M | -$2,214M |
| Net Income (Loss) to Intel | $1,689M | -$18,756M | **-$267M** |
| EPS (diluted) | $0.40 | -$4.38 | **-$0.06** |
Revenue has declined for three consecutive years: $54.2B, $53.1B, $52.9B. Operating loss narrowed from -$11.7B to -$2.2B — but only because FY2024 included $6.97B in restructuring charges (vs $2.19B in FY2025) and $3.3B in manufacturing asset impairments.
The filing reveals the 2024 "kitchen sink" that makes 2025 look better: "$3.3 billion of charges, substantially all of which were recorded to cost of sales, related to non-cash impairments and the acceleration of depreciation for certain manufacturing assets, a substantial majority of which related to our Intel 7 process node; $3.1 billion of non-cash charges associated with the impairment of goodwill for certain of our reporting units as well as certain acquired intangible assets; and $9.9 billion of non-cash charges recorded to provision for income taxes that substantially related to valuation allowances recorded to our net deferred tax assets."
The important line: interest and other net income of $3,257M in 2025 (vs $226M in 2024) included a $5.3B gain on divestitures. Without this, the operating loss would have been the dominant story.
Cash Flow: Three Years of Negative FCF
Per the consolidated statements of cash flows:
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Income (Loss) | $1,675M | -$19,233M | $26M |
| Operating Cash Flow | $11,471M | $8,288M | $9,697M |
| CapEx | -$25,750M | -$23,944M | -$14,646M |
| Govt Incentive Proceeds | $1,011M | $1,936M | $1,577M |
| **Adj. FCF** | **-$14,279M** | **-$15,656M** | **-$4,949M** |
Free cash flow has been negative for three consecutive years, burning a cumulative $34.9B. The improvement in FY2025 is primarily from cutting CapEx nearly in half — from $23.9B to $14.6B. The filing confirms Intel has "delayed or cancelled manufacturing facility construction or expansion projects in Ohio, Germany, Poland, Malaysia and Israel."
Partner contributions (SCIP partnerships) provided $5.1B in FY2025 cash — these are equity-like arrangements where partners fund fab construction in exchange for future capacity. They are not revenue and not operating cash flow, but they are keeping Intel afloat.
The Government Equity Dilution
The balance sheet shows common shares outstanding surged from 4,330M to 4,994M — a 15% dilution. The filing explains this through CHIPS Act equity conversion and SCIP partner arrangements. Total Intel stockholders' equity rose from $99.3B to $114.3B, but non-controlling interests also grew from $5.8B to $12.1B.
Per the balance sheet:
| Item | 2024 | 2025 |
|---|---|---|
| Cash + Short-term Investments | $22,062M | $37,416M |
| Total Debt (current + long-term) | $49,011M | $46,585M |
| Goodwill | $24,693M | $23,912M |
| Total Assets | $196,485M | $211,429M |
| PP&E, net | $107,919M | $105,414M |
| Total Intel Stockholders' Equity | $99,270M | $114,281M |
Cash position improved significantly — from $22.1B to $37.4B — driven by equity issuance and SCIP contributions, not operations.
Goodwill: The Mobileye Question
Goodwill of $23.9B represents 11.3% of total assets. The 10-K discloses the FY2024 Mobileye impairment: "We recognized a non-cash goodwill impairment charge of $2.8 billion in the third quarter of 2024, substantially all of which related to our Mobileye reporting unit, as the estimated fair value of the reporting unit was lower than the assigned carrying value."
The filing adds that in Q4 2024, "While no additional impairment was recognized during the fourth quarter of 2024 for the Mobileye reporting unit," the fair value barely exceeded carrying value. With Mobileye's market capitalization still depressed, further impairment risk remains.
The 18-Point Screening
| # | Check | Result | Detail |
|---|---|---|---|
| A1 | DSO Change | PASS | DSO 27 days, +3 days YoY. Stable |
| A2 | AR vs Revenue Growth | **FAIL** | AR outpaced revenue for 2 consecutive years |
| A3 | Revenue vs CFFO | PASS | Revenue -0.5%, CFFO +17.0%. Cash improved |
| B1 | Inventory vs COGS | PASS | Inventory -4.8% vs COGS -3.6%. Normal |
| B2 | CapEx vs Revenue | PASS | CapEx -38.8% vs revenue -0.5%. CapEx cut aggressively |
| B3 | SG&A Ratio | PASS | SG&A/Gross Profit = 25.2%, excellent |
| B4 | Gross Margin | PASS | 34.8%, +2.1pp from 2024. Improving but still depressed vs 2023 (40%) |
| C1 | CFFO vs Net Income | WATCH | CFFO/NI = -36.3 (distorted by near-zero net loss). Below 1.0 |
| C2 | Free Cash Flow | WATCH | FCF is negative (-$4.9B). Third consecutive year |
| C3 | Accruals Ratio | PASS | -4.7%. Low accruals |
| C4 | Cash vs Debt | WATCH | Cash $37.4B covers 80% of debt $46.6B. Improved |
| D1 | Goodwill + Intangibles | PASS | $26.7B = 23% of equity. Manageable but includes Mobileye risk |
| D2 | Leverage | WATCH | Interest coverage -0.02x (<2x). Financial stress — operating loss |
| D3 | Soft Asset Growth | PASS | Other assets -4.6% vs revenue -0.5%. Normal |
| D4 | Asset Impairment | PASS | Write-offs normalized after FY2024 kitchen sink |
| E1 | Serial Acquirer FCF | **FAIL** | FCF after acquisitions negative for 3 consecutive years |
| E2 | Goodwill Surge | PASS | Goodwill -6% YoY. Declining (amortization + impairment) |
| F1 | Beneish M-Score | PASS | M-Score = -2.59. Below -2.22. Clean |
Beneish M-Score Component Breakdown:
| Component | Value | What It Measures | Concern? |
|---|---|---|---|
| DSRI | 1.109 | Days Sales in Receivables | Slightly elevated |
| GMI | 0.940 | Gross Margin Index — improved | Good |
| AQI | 0.954 | Asset Quality Index | Normal |
| SGI | 0.995 | Sales Growth Index — flat revenue | Neutral |
| DEPI | 0.954 | Depreciation Index | Normal |
| SGAI | 0.844 | SG&A Index — cost cuts | Good |
| TATA | -0.047 | Total Accruals to Assets — negative | Good |
| LVGI | 0.858 | Leverage Index — deleveraging | Good |
The M-Score reads "clean" at -2.59, but this has limited diagnostic value. The model was designed for profitable companies manipulating earnings upward. Intel is reporting losses — there is no incentive to inflate earnings, and the model cannot detect problems that manifest as suppressed write-offs or deferred restructuring charges.
Key Risks from the 10-K
1. Foundry Business Viability
Per Item 1A: "We have limited experience in the highly competitive and capital-intensive third-party foundry business. As we pursue our strategy to establish Intel Foundry as a major provider of foundry capacity to manufacture semiconductors for others, we face intense competition from well-established competitors such as TSMC, Samsung, Global Foundries, UMC and SMIC."
The filing warns: "many of the largest potential foundry customers are fabless semiconductor companies whose products compete with our own." This fundamental conflict of interest makes customer acquisition extremely difficult.
2. Supply Constraints Limiting Revenue
The 10-K reveals a paradox: Intel is cutting CapEx while simultaneously running into supply constraints. "Client volume decreased in Q4 2025 as market demand exceeded our available supply of products due to Intel Foundry wafer fabrication supply constraints, primarily with respect to our Intel 7 process node. We expect these supply constraints to persist into 2026, with the most severe constraints impacting Q1 2026."
3. Competitive Erosion in AI
The filing acknowledges falling behind: "We have similarly had delays in our development of new process technologies and advanced packaging techniques... These delays have allowed competitors using third-party foundries, such as TSMC, to benefit from advancements in manufacturing processes introduced ahead of us." Intel's DCAI server revenue grew just 5% in a year where NVIDIA's data center revenue grew 68%.
4. Restructuring Not Over
Per the filing: Intel initiated a new 2025 Restructuring Plan after the 2024 plan. The 10-K states the company recognized "$348 million in 2025" from the 2024 plan plus "$2,191 million" in total restructuring charges in FY2025. Employee count dropped from 108,900 to 85,100 — a 22% reduction.
5. Government Equity Dilution
Per the risk factors: "The U.S. government's acquisition of significant equity interests in us" is listed as a forward-looking risk. The CHIPS Act converted $7.9B in funding to equity, diluting existing shareholders. The filing warns this could limit "our ability to distribute capital to shareholders."
Key Financial Trends (4-Year)
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $63.1B | $54.2B | $53.1B | $52.9B |
| Net Income (Loss) | $8.0B | $1.7B | -$18.8B | -$0.3B |
| Gross Margin | 42.6% | 40.0% | 32.7% | 34.8% |
| Net Margin | 12.7% | 3.1% | -35.3% | -0.5% |
| ROE | 7.9% | 1.6% | -18.9% | -0.2% |
| CFFO | $15.4B | $11.5B | $8.3B | $9.7B |
| FCF | -$9.4B | -$14.3B | -$15.7B | -$4.9B |
| Cash + ST Investments | $28.3B | $25.0B | $22.1B | $37.4B |
| Total Debt | $42.0B | $49.3B | $50.0B | $46.6B |
| Employees | -- | -- | 108,900 | 85,100 |
Summary
Grade: D. Two red flags and four watch items. The turnaround narrative lacks evidence.
Intel's FY2025 numbers look like stabilization: the net loss narrowed from -$18.8B to -$267M, gross margin improved 2.1 percentage points, and cash position strengthened to $37.4B. But the stabilization is largely cosmetic — FY2024 was a "kitchen sink" year that cleared $16.3B in impairments and write-downs, making any comparison favorable.
The two confirmed red flags:
Additional concerns: Intel Foundry lost $30.7B in three years with only $307M in external revenue. Mobileye's $8.3B goodwill is fragile after a $2.8B impairment. Interest coverage is effectively zero. Revenue has declined for three straight years. Employee headcount was cut 22%.
The M-Score reads clean, but this is not reassuring — a loss-making company has no incentive to inflate earnings. The Altman Z-Score of 3.25 says solvency is safe for now, but this is being supported by equity dilution ($7.9B in government equity) and partner capital, not operating cash flow.
Intel is not eliminated on financial manipulation grounds. It is eliminated on business fundamentals: a dying foundry strategy, competitive erosion in AI, negative free cash flow, and a turnaround that depends on process technology breakthroughs (Intel 18A) that the filing itself describes as "highly risky and our success highly uncertain."
**Disclaimer**: This report is based on Intel Corporation's fiscal year 2025 10-K filed with the SEC on January 22, 2026. This is NOT investment advice.
**About EarningsGrade**: We screen earnings reports for financial red flags using an 18-point forensic framework. Grade D means significant concerns were detected that warrant thorough investigation.
